| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.31 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |